ATROMAC-FA: Comprehensive Control for Cholesterol and Cardiovascular Health
ATROMAC-FA is an advanced lipid-regulating medication designed to provide powerful control over high cholesterol and triglyceride levels, thereby mitigating significant cardiovascular risks. This formulation combines two highly effective ingredients: Atorvastatin, one of the most widely prescribed statins, and Fenofibrate, a potent fibric acid derivative. This dual-action approach is particularly suited for patients suffering from mixed dyslipidemia (elevated LDL-C and triglycerides with low HDL-C). By targeting multiple aspects of lipid metabolism, ATROMAC-FA offers a comprehensive therapeutic strategy to optimize the lipid profile and protect against the progression of atherosclerosis.
The Dual Mechanism: Atorvastatin and Fenofibrate Synergy
The efficacy of ATROMAC-FA stems from the synergistic action of its components. Atorvastatin works primarily by inhibiting the HMG-CoA reductase enzyme in the liver, which is essential for cholesterol production. This results in a significant reduction in LDL-C ("bad" cholesterol) and total cholesterol levels. Complementing this is Fenofibrate, which activates the PPAR-alpha receptor. This activation leads to a marked reduction in VLDL and triglyceride levels while also raising protective HDL-C ("good" cholesterol). By combining these two powerful drugs, ATROMAC-FA achieves better overall lipid goal attainment than either drug used alone, making it a cornerstone for aggressive lipid management.
Proactive Protection Against Atherosclerosis and Heart Events
Uncontrolled dyslipidemia is a major silent risk factor for severe cardiovascular events. ATROMAC-FA plays a critical role in proactive disease management by not only improving blood lipid profiles but also contributing to the stabilization of atherosclerotic plaques. The reduction in LDL-C and triglycerides directly limits the material available for plaque formation, while Fenofibrate?s action on HDL-C helps facilitate the removal of cholesterol from artery walls. For patients with a high risk of Myocardial Infarction (heart attack) and Stroke, incorporating ATROMAC-FA into their regimen is a vital step toward reducing morbidity and mortality associated with coronary artery disease.
Quality Assurance for Long-Term Lipid Management
As a key product from MK Healthcare, an ISO-GMP certified pharmaceutical provider, ATROMAC-FA is manufactured to the highest standards of quality and consistency. It offers a convenient, fixed-dose combination, simplifying the patient's medication schedule and promoting better adherence to the long-term therapy required for effective lipid management. If you are struggling to achieve your target cholesterol levels with a single agent, discuss the benefits of ATROMAC-FA with your physician. This combination tablet provides an effective, reliable, and comprehensive solution for managing
What is MK Healthcare ATROMAC-FA Tablet primarily used for?
ATROMAC-FA is a combination medication used to treat high lipid levels (dyslipidemia), specifically elevated cholesterol (LDL-C) and high triglycerides. By improving the lipid profile, it helps in the prevention of heart diseases, heart attacks, and strokes.
What are the two active ingredients in ATROMAC-FA and how do they work?
The tablet combines two potent lipid-lowering agents:
Atorvastatin (a Statin): Works by inhibiting the HMG-CoA reductase enzyme in the liver, significantly reducing the production of LDL ("bad") cholesterol.
Fenofibrate (a Fibrate): Works primarily by activating the PPAR-alpha receptor, leading to a marked reduction in triglycerides and very low-density lipoprotein (VLDL), while slightly increasing HDL ("good") cholesterol.
Why is this combination of Atorvastatin and Fenofibrate prescribed?
The combination is prescribed for patients with mixed dyslipidemia (high LDL-C and high triglycerides with often low HDL-C) who have not achieved adequate control with Atorvastatin alone. The dual action targets multiple facets of fat metabolism, offering a more comprehensive and aggressive lipid-lowering effect to reduce cardiovascular risk.
How does ATROMAC-FA reduce the risk of heart attack and stroke?
By effectively lowering both LDL cholesterol and triglycerides, ATROMAC-FA reduces the deposition of fat (plaque) in the artery walls. This process, known as preventing atherosclerosis, keeps the arteries clear, improves blood flow, and dramatically reduces the chances of blockages that cause heart attacks or strokes.
What is the role of ATROMAC-FA in increasing "good cholesterol" (HDL)?
The Fenofibrate component in ATROMAC-FA is particularly effective in boosting the level of HDL cholesterol. HDL is beneficial as it helps to remove excess cholesterol from the arteries and transport it back to the liver for excretion, providing an added layer of cardiovascular protection.
Can ATROMAC-FA cause muscle pain or weakness?
Yes. A common and potentially serious side effect of statin drugs like Atorvastatin is myopathy (muscle pain or weakness). In rare cases, this can progress to rhabdomyolysis. Patients must immediately report any unexplained muscle pain, tenderness, or weakness to their doctor, especially if accompanied by fever or fatigue.
Is ATROMAC-FA safe for patients with liver or kidney problems?
ATROMAC-FA is not recommended for patients with active or severe liver disease, as both components are metabolized by the liver and can elevate liver enzymes. It should also be used with caution in patients with kidney disease, and a dosage adjustment may be needed. Regular liver and kidney function tests are mandatory while on this medication.
When is the best time of day to take the ATROMAC-FA tablet?
The tablet is generally taken once daily. While the manufacturer often advises taking it with or without food, many lipid-lowering medications are recommended to be taken at bedtime or in the evening, as cholesterol production in the liver is typically higher overnight. Always follow your doctor's specific dosing instructions.
Can I stop taking ATROMAC-FA if my cholesterol numbers improve?
No, you should never stop taking ATROMAC-FA without consulting your doctor. High cholesterol and triglyceride levels are chronic conditions. Stopping the medication, even after numbers have normalized, will likely cause your lipid levels to rise again, significantly increasing your risk of heart attack and stroke.
